Aurora kinases A and B are required for KRAS-induced lung cell oncogenicity (2014)
- Authors:
- Autor USP: BASSÈRES, DANIELA SANCHEZ - IQ
- Unidade: IQ
- Subjects: ONCOGENES; NEOPLASIAS DO TRATO RESPIRATÓRIO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: European Journal of Cancer
- ISSN: 0959-8049
- Volume/Número/Paginação/Ano: v. 50, Suppl. 6, p. 129 res. 405, 2014
- Conference titles: EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
-
ABNT
SANTOS, Edmilson Ozorio dos et al. Aurora kinases A and B are required for KRAS-induced lung cell oncogenicity. European Journal of Cancer. Oxford: Instituto de Química, Universidade de São Paulo. . Acesso em: 28 mar. 2024. , 2014 -
APA
Santos, E. O. dos, Aoki, M. N., Levantini, E., & Bassères, D. S. (2014). Aurora kinases A and B are required for KRAS-induced lung cell oncogenicity. European Journal of Cancer. Oxford: Instituto de Química, Universidade de São Paulo. -
NLM
Santos EO dos, Aoki MN, Levantini E, Bassères DS. Aurora kinases A and B are required for KRAS-induced lung cell oncogenicity. European Journal of Cancer. 2014 ; 50 129 res. 405.[citado 2024 mar. 28 ] -
Vancouver
Santos EO dos, Aoki MN, Levantini E, Bassères DS. Aurora kinases A and B are required for KRAS-induced lung cell oncogenicity. European Journal of Cancer. 2014 ; 50 129 res. 405.[citado 2024 mar. 28 ] - Aurora kinases: potential therapeutic targets in K-Ras-induced lung cancer
- Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression
- FOXO1 inhibition by oncogenic KRAS as an important mechanism promoting lung oncogenesis
- Requirement of the NF-'capa' B subunit p65/RelA for 'capa'-Ras-induced lung tumorigenesis
- Resenha sem título próprio
- Targeting Aurora kinase activity in lung cancer cell driven by oncogenic KRAS impairs lung cancer initiating cell function
- Exploring IKKβ as an anti-angiogenic therapeutic target in KRAS-induced lung cancer
- IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity
- Exploring IKKβ kinase as a therapeutic target for KRAS-driven lung tumor initiating cells
- Exploring IKKβ as an anti-metastatic therapeutic target in KRAS-induced lung cancer
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas